21 May 2009
Anemia prevalence and a possible role of hepcidin in its pathogenesis in kidney allograft recipients
J Malyszko, J Malyszko, M MysliwiecAnn Transplant 2009; 14(1): 48-49 :: ID: 880376
Abstract
Hepcidin is a small defensin-like peptide whose production by hepatocytes is modulated in response to anaemia, hypoxia or infl ammation. We studied hepcidin correlations with markers of iron status, erythropoietin therapy and markers of inflammation in 100 prevalent kidney allograft recipients-Tx. In addition, prevalence of anaemia and its relation to hepcidin was also assessed. Soluble receptor of transferrin-sTfR hsCRP, TNF alpha, IL-6, prohepcidin and hepcidin were measured using commercially available kits.According to WHO definition, prevalence of anaemia was 28%. In anaemic Tx we found a significantly higher serum creatinine, serum prohepcidin, hepcidin, CRP, TNF alpha, IL-6, ferritin, proteinuria, higher use of rapamycin (n=8), and significantly lower use of CSA, lower CSA concentration, lower cholesterol, lower haemoglobin, lower eGFR (MDRD). Serum prohepcidin correlated significantly with creatinine, GFR, time after transplantation, albumin, hsCRP, IL-6 and TNF alpha, whereas hepcidin-25 correlated with serum iron, ferritin, CRP, IL-6, haemoglobin, TSAT, creatinine, GFR. Multiple regression analysis showed that prohepcidin was independently related only to GFR and ferritin. In multiple regressions analysispredictors of serum hepcidin were eGFR, TSAT and hsCRP explaining 79% of the variation of hepcidin.
Conclusions: Prevalence of anaemia is relatively high in population of kidney allograft recipients and not adequately treated (mainly due to reimbursement regulations). Elevated hepcidin levels in kidney transplant recipients may be due to low grade inflammation, frequently encountered in this population and mainly to impaired renal function, but it does not seem to be a major pathogenetic factor of anaemia in this population.
Keywords: Kidney Transplantation
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860